ProCE Banner Series

Frontiers in RSV Prevention for Older Adults: Developments, Recommendations, and the Pharmacist’s Role

Recently, the FDA approved the first 2 RSV vaccines for adults aged 60 years or older. As healthcare professionals serving in key roles throughout care settings, we welcome pharmacists to join us in this multimodal educational program to learn strategies to incorporate RSV vaccination in your practice, methods of identifying patients who would benefit from RSV prevention, and tools to provide evidence-based and up-to-date education.

Please click the green “Learn More” button below. Once registered, you will receive a confirmation email. Follow-up emails with details will be sent as the event nears.

  ACPE
Credits Available

1.0

Who Should Attend

The target audience for this program is pharmacists, including community, ambulatory care, health-system, and infectious diseases pharmacists, as well as other pharmacy professionals involved in the care of adults eligible for RSV immunization.

Faculty

ProCE Banner Faculty
Mary Barna Bridgeman, PharmD, BCPS, BCGP, FASCP, FCCP, FNAP

Clinical Professor
Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey
Piscataway, New Jersey
Internal Medicine Pharmacist
Robert Wood Johnson University Hospital New Brunswick
New Brunswick, New Jersey

ProCE Banner Faculty
Christina M. Madison, PharmD, FCCP, BCACP, AAHIVP

Clinical Pharmacist
Founder and CEO, The Public Health Pharmacist, PLLC
Adjunct Associate Professor of Pharmacy Practice
Roseman University of Health Sciences
College of Pharmacy
Henderson, Nevada

Topics

  • Introduction and Baseline Assessment
  • Surveying the Landscape: Annual Burden of RSV in Older Adults
  • Light on the Horizon: Developments in RSV Vaccines
  • Trailblazers: Pharmacist’s Role in Optimizing New RSV Vaccines for Older Adults
  • Question and Answer Session

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Vaccination.

Target Audience
The target audience for this program is pharmacists, including community, ambulatory care, health-system, and infectious diseases pharmacists, as well as other pharmacy professionals involved in the care of adults eligible for RSV immunization. 

Learning Objectives

  • Describe the burden of RSV infections in older adults including disease manifestations and risk factors for severe outcomes
  • Compare available and emerging RSV vaccines for older adults including mechanisms of action and safety and efficacy data
  • Optimize uptake of RSV vaccination in older adults using evidence-based shared clinical decision-making principles

Accreditation

CE Accreditation

Pharmacists

This activity is jointly provided by ProCE, LLC and Clinical Care Options, LLC. ProCE, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-23-028-L06-P has been assigned to this live application-based activity (initial release date 11/9/2023). This activity is approved for 1.0 contact hour (0.10 CEU) in states that recognize ACPE providers. This activity is provided at no cost to participants. Participants must complete the online post-test and activity evaluation within 30 days of the activity to receive pharmacy CE credit. No partial credit will be given. Statements of completion will be issued online at www.ProCE.com, and proof of completion will be posted in NABP CPE Monitor profiles.

Disclosure
ProCE requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to ProCE policy. ProCE is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by ProCE, LLC, in partnership with Clinical Care Options, LLC

Supported by an educational grant from Pfizer Inc.